Dr Lal Pathlabs Ltd Share Price ₹1,602

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Dr Lal Pathlabs Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	491	541	601	539	545	602	660	597	603	670	731	660	703
Expenses +	375	395	424	398	401	432	458	443	434	478	506	480	516
Operating Profit	116	146	178	141	145	170	202	154	169	192	224	179	187
OPM %	24%	27%	30%	26%	27%	28%	31%	26%	28%	29%	31%	27%	27%
Other Income +	14	14	18	18	18	21	22	25	26	28	25	-6	24
Interest	9	8	8	7	7	6	6	5	5	5	5	7	6
Depreciation	38	35	36	36	37	35	35	36	36	35	40	42	45
Profit before tax	83	118	152	116	120	150	183	138	153	181	204	124	160
Tax %	32%	29%	27%	29%	28%	28%	29%	29%	-1%	26%	25%	26%	17%
Net Profit +	57	84	111	82	86	108	131	98	156	134	152	91	132
EPS in Rs	3.40	4.95	6.55	4.87	5.06	6.37	7.73	5.78	9.26	7.90	8.99	5.40	7.84

Financials of Dr Lal Pathlabs Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	660	791	912	1,057	1,203	1,330	1,581	2,087	2,017	2,227	2,461	2,763
Expenses +	504	582	675	793	910	987	1,145	1,526	1,527	1,617	1,764	1,980
Operating Profit	156	210	238	264	294	344	436	561	490	609	698	782
OPM %	24%	26%	26%	25%	24%	26%	28%	27%	24%	27%	28%	28%
Other Income +	12	20	27	31	46	55	51	52	42	69	91	71
Interest	0	0	1	1	1	15	16	30	38	29	22	23
Depreciation	28	28	28	33	38	73	77	108	150	144	142	162
Profit before tax	140	201	237	261	301	310	394	475	344	505	625	669
Tax %	31%	34%	34%	34%	33%	27%	25%	26%	30%	28%	21%	24%
Net Profit +	96	133	156	172	200	228	296	350	241	362	492	510
EPS in Rs	8.75	7.99	9.31	10.24	11.95	13.55	17.49	20.69	14.33	21.42	29.14	30.13
Dividend Payout %	9%	15%	16%	22%	25%	44%	57%	29%	42%	0%	0%	81%

Financials of Dr Lal Pathlabs Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	55	83	83	83	83	83	83	83	83	83	84	168
Reserves	260	425	512	705	862	949	1,162	1,418	1,583	1,766	2,089	2,341
Borrowings +	27	0	0	0	0	0	150	533	420	247	157	199
Other Liabilities +	134	118	95	128	145	341	265	309	297	357	383	439
Total Liabilities	475	625	690	916	1,091	1,374	1,661	2,343	2,383	2,454	2,713	3,146
Fixed Assets +	150	166	152	208	209	413	447	1,369	1,305	1,228	1,168	1,257
CWIP	1	4	18	10	3	11	10	15	5	6	3	6
Investments	38	64	106	145	185	164	59	65	150	114	327	423
Other Assets +	286	391	414	554	694	786	1,144	893	923	1,107	1,215	1,461
Total Assets	475	625	690	916	1,091	1,374	1,661	2,343	2,383	2,454	2,713	3,146

Financials of Dr Lal Pathlabs Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	122	159	171	197	219	284	398	447	456	535	569	636
Cash from Investing Activity +	-113	-163	-137	-172	-100	-26	-212	-449	-287	-24	-303	-422
Cash from Financing Activity +	-1	0	-32	13	-55	-190	-139	136	-283	-414	-334	-264
Net Cash Flow	8	-5	2	37	64	67	48	134	-114	97	-68	-50
Free Cash Flow	87	115	120	125	177	205	339	-28	412	479	516	463
CFO/OP	112%	108%	102%	110%	110%	110%	115%	103%	115%	110%	105%	104%

Financials of Dr Lal Pathlabs Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	17	17	17	14	16	14	15	15	13	13	13	15
Inventory Days	37	31	33	44	40	70	39	38	28	30	27	30
Days Payable	90	89	97	106	111	144	132	107	127	151	151	123
Cash Conversion Cycle	-35	-42	-47	-47	-55	-60	-78	-54	-87	-108	-110	-79
Working Capital Days	-9	27	19	17	0	-19	-26	-54	-56	-46	-30	27
ROCE %	48%	47%	43%	38%	35%	32%	33%	29%	18%	25%	29%	28%